Lundbeck upgrades annual guidance
The Danish pharmaceutical company upgrades its full-year guidance for both revenue and operating result.
BY ANDREAS LØNSRTUP, TRANSLATED BY DANIEL FRANK CHRISTENSEN
A day before presenting its third-quarter financial statement, Danish pharmaceutical firm Lundbeck now raises its annual outlook for both the top and bottom lines.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
